Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors' reply

Collaboration

Year: 2023

Borque-Fernando, A; Calleja-Hernández, MA; Cózar-Olmo, JM; Gómez-Iturriaga, A; Pérez-Fentes, DA; Puente-Vázquez, J; Rodrigo-Aliaga, M; Unda, M; Alvarez-Ossorio, J.L.

Title: ACTAS UROLOGICAS ESPANOLAS

• Q4